{"transactions":[{"id":691967,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25049,"kind":"organization","name":"Cormorant Private Healthcare Fund VI, LP","position":6,"cik":"0002098185","reported_name":"Cormorant Private Healthcare Fund VI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-08-10T22:32:08.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":1701541,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents (i) 274,912 shares issued upon conversion of shares of Series B Preferred Stock beneficially owned by Master Fund, (ii) 1,052,460 shares issued upon conversion of shares of Series B Preferred Stock beneficially owned by Fund V and (iii) 374,169 shares issued upon conversion of shares of Series B Preferred Stock beneficially owned by Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund V, LP (\"Fund V\") and Cormorant Private Healthcare Fund VI, LP (\"Fund VI\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP III, LLC (\"GP III\"), Cormorant Private Healthcare GP V, LLC (\"GP V\") and Cormorant Private Healthcare GP VI, LLC\n(\"GP VI\") serve as General Partner of the Master Fund, Fund III, Fund V and Fund VI, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bihua Chen serves as manager of Cormorant, GP LLC, GP III, GP V and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1701541},"source":{"system":"sec-edgar","filing":"0001231919-26-000852","document":"form4-08102026_100859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000123191926000852/form4-08102026_100859.xml","form_type":"4"}},{"id":691966,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25049,"kind":"organization","name":"Cormorant Private Healthcare Fund VI, LP","position":6,"cik":"0002098185","reported_name":"Cormorant Private Healthcare Fund VI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-08-10T22:32:08.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":1599993,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents (i) 1,228,315 shares issued upon conversion of shares of Series A Preferred Stock beneficially owned by Fund III (defined below), and (ii) 371,678 shares issued upon conversion of shares of Series A Preferred Stock beneficially owned by Master Fund (defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund V, LP (\"Fund V\") and Cormorant Private Healthcare Fund VI, LP (\"Fund VI\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP III, LLC (\"GP III\"), Cormorant Private Healthcare GP V, LLC (\"GP V\") and Cormorant Private Healthcare GP VI, LLC\n(\"GP VI\") serve as General Partner of the Master Fund, Fund III, Fund V and Fund VI, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bihua Chen serves as manager of Cormorant, GP LLC, GP III, GP V and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1599993},"source":{"system":"sec-edgar","filing":"0001231919-26-000852","document":"form4-08102026_100859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000123191926000852/form4-08102026_100859.xml","form_type":"4"}},{"id":691965,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25049,"kind":"organization","name":"Cormorant Private Healthcare Fund VI, LP","position":6,"cik":"0002098185","reported_name":"Cormorant Private Healthcare Fund VI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-08-10T22:32:08.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":23904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/36th of the shares subject to the option shall vest in equal monthly installments over a three year period following August 6, 2026."}],"balance_after":23904,"derivative":{"exercise_price":16,"expiration_date":"2036-08-05","underlying":"Common Stock","underlying_shares":23904},"source":{"system":"sec-edgar","filing":"0001231919-26-000852","document":"form4-08102026_100859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000123191926000852/form4-08102026_100859.xml","form_type":"4"}},{"id":691964,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25049,"kind":"organization","name":"Cormorant Private Healthcare Fund VI, LP","position":6,"cik":"0002098185","reported_name":"Cormorant Private Healthcare Fund VI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T22:32:08.000Z","date":"2026-08-10","kind":"purchase","planned":false,"acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The shares purchased are beneficially owned by Master Fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Represents an aggregate of (i) 959,090 shares beneficially owned by Master Fund, (ii) 1,228,315 shares beneficially owned by Fund III, (iii) 1,052,460 shares beneficially owned by Fund V, and (vi) 374,169 beneficially owned by Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund V, LP (\"Fund V\") and Cormorant Private Healthcare Fund VI, LP (\"Fund VI\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP III, LLC (\"GP III\"), Cormorant Private Healthcare GP V, LLC (\"GP V\") and Cormorant Private Healthcare GP VI, LLC\n(\"GP VI\") serve as General Partner of the Master Fund, Fund III, Fund V and Fund VI, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bihua Chen serves as manager of Cormorant, GP LLC, GP III, GP V and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":3614034,"source":{"system":"sec-edgar","filing":"0001231919-26-000852","document":"form4-08102026_100859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000123191926000852/form4-08102026_100859.xml","form_type":"4"}},{"id":691963,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25049,"kind":"organization","name":"Cormorant Private Healthcare Fund VI, LP","position":6,"cik":"0002098185","reported_name":"Cormorant Private Healthcare Fund VI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T22:32:08.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":1701541,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents (i) 274,912 shares issued upon conversion of shares of Series B Preferred Stock beneficially owned by Master Fund, (ii) 1,052,460 shares issued upon conversion of shares of Series B Preferred Stock beneficially owned by Fund V and (iii) 374,169 shares issued upon conversion of shares of Series B Preferred Stock beneficially owned by Fund VI."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents an aggregate of (i) 646,590 shares beneficially owned by Master Fund, (ii) 1,228,315 shares beneficially owned by Fund III, (iii) 1,052,460 shares beneficially owned by Fund V, and (vi) 374,169 beneficially owned by Fund VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund V, LP (\"Fund V\") and Cormorant Private Healthcare Fund VI, LP (\"Fund VI\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP III, LLC (\"GP III\"), Cormorant Private Healthcare GP V, LLC (\"GP V\") and Cormorant Private Healthcare GP VI, LLC\n(\"GP VI\") serve as General Partner of the Master Fund, Fund III, Fund V and Fund VI, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bihua Chen serves as manager of Cormorant, GP LLC, GP III, GP V and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":3301534,"source":{"system":"sec-edgar","filing":"0001231919-26-000852","document":"form4-08102026_100859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000123191926000852/form4-08102026_100859.xml","form_type":"4"}},{"id":691962,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25049,"kind":"organization","name":"Cormorant Private Healthcare Fund VI, LP","position":6,"cik":"0002098185","reported_name":"Cormorant Private Healthcare Fund VI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T22:32:08.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":1599993,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents (i) 1,228,315 shares issued upon conversion of shares of Series A Preferred Stock beneficially owned by Fund III (defined below), and (ii) 371,678 shares issued upon conversion of shares of Series A Preferred Stock beneficially owned by Master Fund (defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents (i) 1,228,315 shares issued upon conversion of shares of Series A Preferred Stock beneficially owned by Fund III (defined below), and (ii) 371,678 shares issued upon conversion of shares of Series A Preferred Stock beneficially owned by Master Fund (defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund V, LP (\"Fund V\") and Cormorant Private Healthcare Fund VI, LP (\"Fund VI\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP III, LLC (\"GP III\"), Cormorant Private Healthcare GP V, LLC (\"GP V\") and Cormorant Private Healthcare GP VI, LLC\n(\"GP VI\") serve as General Partner of the Master Fund, Fund III, Fund V and Fund VI, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Bihua Chen serves as manager of Cormorant, GP LLC, GP III, GP V and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1599993,"source":{"system":"sec-edgar","filing":"0001231919-26-000852","document":"form4-08102026_100859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000123191926000852/form4-08102026_100859.xml","form_type":"4"}},{"id":797438,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Shares","published_at":"2026-04-30T20:07:58.000Z","date":"2026-04-28","kind":"sale","planned":false,"acquired":false,"shares":109331,"price":89.5,"value":9785124.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as the general partner of the Master Fund. Bihua Chen serves as the managing member of Cormorant, GP LLC and the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":950000,"source":{"system":"sec-edgar","filing":"0000929638-26-001708","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963826001708/form4.xml","form_type":"4"}},{"id":968846,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-12-15T21:18:06.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":30029,"price":11.456,"value":344012.224,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price represents the weighted average sale price of Common Stock (the \"shares\") sold in a series of open market transactions on the transaction date at prices ranging from $11.20 to $12.15 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as the general partner of the Master Fund. Bihua Chen serves as the managing member of Cormorant, GP LLC and the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2344971,"source":{"system":"sec-edgar","filing":"0000929638-25-004597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963825004597/form4.xml","form_type":"4"}},{"id":977411,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-12-08T21:03:52.000Z","date":"2025-12-04","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":15.704,"value":942240.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price represents the weighted average sale price of Common Stock (the \"shares\") sold in a series of open market transactions on the transaction date at prices ranging from $15.70 to $15.97 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as the general partner of the Master Fund. Bihua Chen serves as the managing member of Cormorant, GP LLC and the Master Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":8265000,"source":{"system":"sec-edgar","filing":"0000929638-25-004521","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963825004521/form4.xml","form_type":"4"}},{"id":1029424,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74740,"kind":"organization","name":"Cormorant Private Healthcare Fund II, LP","position":4,"cik":"0001747677","reported_name":"Cormorant Private Healthcare Fund II, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":5,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":6,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A Ordinary Shares","published_at":"2025-10-01T21:22:38.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":5827,"price":6.96,"value":40555.92,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price of Class A Ordinary Shares (\"Shares\") sold in a series of open market transactions on the transaction date at prices ranging from $6.94 to $6.99 per Share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of Shares sold at each price. All of these Shares were sold by the Account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Information reported herein relates to Shares owned by Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund II, LP (\"Fund II\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and a managed account (the \"Account\" and together with the Master Fund, Fund II, Fund III and Fund IV, the \"Funds\")). Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of the Funds. Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP II, LLC (\"GP II\"), Cormorant Private Healthcare GP III, LLC (\"GP III\") and Cormorant Private Healthcare GP IV, LLC (\"GP IV\") serve as General Partner of the Master Fund, Fund II, Fund III and Fund IV, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP II, GP III and GP IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such ordinary shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Represents (i) 638,740 Shares beneficially owned by the Master Fund, (ii) 424,466 Shares beneficially owned by Fund II, (iii) 577,783 Shares beneficially owned by Fund III, and (iv) 353,184 Shares beneficially owned by Fund IV."}],"balance_after":1994173,"source":{"system":"sec-edgar","filing":"0000929638-25-003712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825003712/form4.xml","form_type":"4"}},{"id":1029423,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74740,"kind":"organization","name":"Cormorant Private Healthcare Fund II, LP","position":4,"cik":"0001747677","reported_name":"Cormorant Private Healthcare Fund II, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":5,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":6,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A Ordinary Shares","published_at":"2025-10-01T21:22:38.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":2800000,"price":6.61,"value":18508000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of Class A Ordinary Shares (\"Shares\") sold in a series of open market transactions on the transaction date at prices ranging from $6.20 to $7.04 per Share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of Shares sold at each price. All of these Shares were sold by the Master Fund, Fund II, Fund III, Fund IV, and the Account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Information reported herein relates to Shares owned by Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund II, LP (\"Fund II\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and a managed account (the \"Account\" and together with the Master Fund, Fund II, Fund III and Fund IV, the \"Funds\")). Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of the Funds. Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP II, LLC (\"GP II\"), Cormorant Private Healthcare GP III, LLC (\"GP III\") and Cormorant Private Healthcare GP IV, LLC (\"GP IV\") serve as General Partner of the Master Fund, Fund II, Fund III and Fund IV, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP II, GP III and GP IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such ordinary shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Represents (i) 638,740 Shares beneficially owned by the Master Fund, (ii) 424,466 Shares beneficially owned by Fund II, (iii) 577,783 Shares beneficially owned by Fund III, (iv) 353,184 Shares beneficially owned by Fund IV, and (v) 5,827 shares beneficially owned by the Account."}],"balance_after":2000000,"source":{"system":"sec-edgar","filing":"0000929638-25-003712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825003712/form4.xml","form_type":"4"}},{"id":1029422,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74740,"kind":"organization","name":"Cormorant Private Healthcare Fund II, LP","position":4,"cik":"0001747677","reported_name":"Cormorant Private Healthcare Fund II, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":5,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":6,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A Ordinary Shares","published_at":"2025-10-01T21:22:38.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":3390943,"price":7.58,"value":25703347.94,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of Class A Ordinary Shares (\"Shares\") sold in a series of open market transactions on the transaction date at prices ranging from $7.30 to $8.18 per Share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of Shares sold at each price. All of these Shares were sold by the Master Fund, Fund II, Fund III, Fund IV, and the Account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Information reported herein relates to Shares owned by Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund II, LP (\"Fund II\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and a managed account (the \"Account\" and together with the Master Fund, Fund II, Fund III and Fund IV, the \"Funds\")). Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of the Funds. Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP II, LLC (\"GP II\"), Cormorant Private Healthcare GP III, LLC (\"GP III\") and Cormorant Private Healthcare GP IV, LLC (\"GP IV\") serve as General Partner of the Master Fund, Fund II, Fund III and Fund IV, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP II, GP III and GP IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such ordinary shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents (i) 1,532,978 Shares beneficially owned by the Master Fund, (ii) 1,018,717 Shares beneficially owned by Fund II, (iii) 1,386,674 Shares beneficially owned by Fund III, (iv) 847,642 Shares beneficially owned by Fund IV, and (v) 13,989 shares beneficially owned by the Account."}],"balance_after":4800000,"source":{"system":"sec-edgar","filing":"0000929638-25-003712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825003712/form4.xml","form_type":"4"}},{"id":1029421,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74740,"kind":"organization","name":"Cormorant Private Healthcare Fund II, LP","position":4,"cik":"0001747677","reported_name":"Cormorant Private Healthcare Fund II, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":5,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":6,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A Ordinary Shares","published_at":"2025-10-01T21:22:38.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":232460,"price":8.4,"value":1952664.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of Class A Ordinary Shares (\"Shares\") sold in a series of open market transactions on the transaction date at prices ranging from $8.20 to $9.02 per Share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of Shares sold at each price. All of these Shares were sold by the Master Fund, Fund II, Fund III, Fund IV, and the Account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Information reported herein relates to Shares owned by Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund II, LP (\"Fund II\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and a managed account (the \"Account\" and together with the Master Fund, Fund II, Fund III and Fund IV, the \"Funds\")). Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of the Funds. Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP II, LLC (\"GP II\"), Cormorant Private Healthcare GP III, LLC (\"GP III\") and Cormorant Private Healthcare GP IV, LLC (\"GP IV\") serve as General Partner of the Master Fund, Fund II, Fund III and Fund IV, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP II, GP III and GP IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such ordinary shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents (i) 2,615,943 Shares beneficially owned by the Master Fund, (ii) 1,738,386 Shares beneficially owned by Fund II, (iii) 2,366,285 Shares beneficially owned by Fund III, (iv) 1,446,456 Shares beneficially owned by Fund IV, and (v) 23,873 shares beneficially owned by the Account."}],"balance_after":8190943,"source":{"system":"sec-edgar","filing":"0000929638-25-003712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825003712/form4.xml","form_type":"4"}},{"id":1029420,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":2,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74740,"kind":"organization","name":"Cormorant Private Healthcare Fund II, LP","position":4,"cik":"0001747677","reported_name":"Cormorant Private Healthcare Fund II, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":5,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":6,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A Ordinary Shares","published_at":"2025-10-01T21:22:38.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":70748,"price":9.38,"value":663616.24,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of Class A Ordinary Shares (\"Shares\") sold in a series of open market transactions on the transaction date at prices ranging from $9.25 to $9.43 per Share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of Shares sold at each price. All of these Shares were sold by the Master Fund (as defined below) , Fund II (as defined below), Fund III (as defined below), Fund IV (as defined below), and the Account (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Information reported herein relates to Shares owned by Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund II, LP (\"Fund II\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and a managed account (the \"Account\" and together with the Master Fund, Fund II, Fund III and Fund IV, the \"Funds\")). Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of the Funds. Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP II, LLC (\"GP II\"), Cormorant Private Healthcare GP III, LLC (\"GP III\") and Cormorant Private Healthcare GP IV, LLC (\"GP IV\") serve as General Partner of the Master Fund, Fund II, Fund III and Fund IV, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP II, GP III and GP IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such ordinary shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents (i) 2,690,183 Shares beneficially owned by the Master Fund, (ii) 1,787,722 Shares beneficially owned by Fund II, (iii) 2,433,441 Shares beneficially owned by Fund III, (iv) 1,487,507 Shares beneficially owned by Fund IV, and (v) 24,550 shares beneficially owned by the Account."}],"balance_after":8423403,"source":{"system":"sec-edgar","filing":"0000929638-25-003712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825003712/form4.xml","form_type":"4"}},{"id":1111890,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:02:39.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":91970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Stock options granted to Bihua Chen, in her capacity as a director of the Issuer."}],"balance_after":91970,"derivative":{"exercise_price":2.5,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":91970},"source":{"system":"sec-edgar","filing":"0000929638-25-002234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825002234/form4.xml","form_type":"4"}},{"id":1142937,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":4,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":6,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A Common Stock","published_at":"2025-05-19T21:33:06.000Z","date":"2025-05-15","kind":"sale","planned":false,"acquired":false,"shares":1813439,"price":1.8545,"value":3363022.6255,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of Class A Common Stock (the \"shares\") sold in a series of open market transactions on the transaction date ranging from $1.85 to $2.03 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000929638-25-001950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825001950/form4.xml","form_type":"4"}},{"id":1149321,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":4,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"ten_percent_owner":true}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":5,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":6,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2025-05-14T20:36:04.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":24300,"price":1.985,"value":48235.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund III, LP (\"Fund III\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (i) 429,934 shares of Class A Common Stock beneficially owned by the Master Fund, (ii) 1,099,451 shares of Class A Common Stock beneficially owned by Fund III, (iii) 234,125 shares of Class A Common Stock beneficially owned by Fund IV, and (iv) 49,929 shares of Class A Common Stock beneficially owned by Fund V."}],"balance_after":1813439,"source":{"system":"sec-edgar","filing":"0000929638-25-001870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963825001870/form4.xml","form_type":"4"}},{"id":1258695,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-02-19T21:02:07.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":6780810,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund, and Cormorant Private Healthcare V GP, LLC (\"GP V LLC\") serves as general partner of Fund V. Bihua Chen serves as the managing member of GP LLC, GP V LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":800189},"source":{"system":"sec-edgar","filing":"0000929638-25-000822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963825000822/form4.xml","form_type":"4"}},{"id":1258694,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-02-19T21:02:07.000Z","date":"2025-02-14","kind":"purchase","planned":false,"acquired":true,"shares":187500,"price":16,"value":3000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund, and Cormorant Private Healthcare V GP, LLC (\"GP V LLC\") serves as general partner of Fund V. Bihua Chen serves as the managing member of GP LLC, GP V LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 298,486 and 689,203 shares of Common Stock beneficially owned by the Master Fund and Fund V, respectively."}],"balance_after":987689,"source":{"system":"sec-edgar","filing":"0000929638-25-000822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963825000822/form4.xml","form_type":"4"}},{"id":1258693,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2025-02-19T21:02:07.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":800189,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering of Common Stock on February 14, 2025, the Series C Convertible Preferred Stock automatically converted into Common Stock at a 1-for-8.474 conversion ratio, after giving effect to a reverse stock split effected by the Issuer on February 5, 2025, for an aggregate of 800,189 shares of Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund, and Cormorant Private Healthcare V GP, LLC (\"GP V LLC\") serves as general partner of Fund V. Bihua Chen serves as the managing member of GP LLC, GP V LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":800189,"source":{"system":"sec-edgar","filing":"0000929638-25-000822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963825000822/form4.xml","form_type":"4"}},{"id":1374685,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-11-06T21:20:48.000Z","date":"2024-11-04","kind":"purchase","planned":false,"acquired":true,"shares":184331,"price":21.7,"value":3999982.7,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.  All of the shares reported herein are held for the account of the Master Fund."}],"balance_after":1059331,"source":{"system":"sec-edgar","filing":"0000929638-24-003752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003752/form4.xml","form_type":"4"}},{"id":1385363,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-16","kind":"purchase","planned":false,"acquired":true,"shares":3107,"price":25.222,"value":78364.754,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $24.78 to $25.705 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":875000,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385362,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-16","kind":"purchase","planned":false,"acquired":true,"shares":7150,"price":24.03,"value":171814.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $23.775 to $24.74 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":871893,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385361,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-16","kind":"purchase","planned":false,"acquired":true,"shares":39743,"price":23.215,"value":922633.745,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $22.76 to $23.73 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":864743,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385360,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":4609,"price":12.3513,"value":56927.1417,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $12.16 to $12.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385359,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":19169,"price":11.7169,"value":224601.2561,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.18 to $12.125 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":820391,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385358,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":2700,"price":9.2624,"value":25008.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $9.26 to $9.31 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":801222,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385357,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":2600,"price":8.804,"value":22890.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $8.80 to $8.905 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":798522,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385356,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":8900,"price":7.3052,"value":65016.28,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $7.28 to $7.59 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":795922,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385355,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":33343,"price":6.4247,"value":214218.7721,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $6.16 to $7.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":787022,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385354,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":63173,"price":5.924,"value":374236.852,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $5.42 to $6.15 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":753679,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1385353,"issuer":{"id":5231,"kind":"organization","name":"BRIGHT MINDS BIOSCIENCES INC."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2024-10-17T21:11:29.000Z","date":"2024-10-15","kind":"purchase","planned":false,"acquired":true,"shares":238097,"price":4.5304,"value":1078674.6488,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of common shares purchased in a series of open market transactions on the transaction date at prices ranging from $4.16 to $4.89 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as general partner of the Master Fund. Bihua Chen serves as the managing member of GP LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":690506,"source":{"system":"sec-edgar","filing":"0000929638-24-003542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827401/000092963824003542/form4.xml","form_type":"4"}},{"id":1396780,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":2,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":4,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Series D Redeemable Convertible Preferred Stock","published_at":"2024-10-01T20:01:04.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":false,"shares":5263772,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (i) 173,704 shares of Series D Preferred Stock beneficially owned by the Master Fund (defined below), which converted into 38,924 shares of Common Stock, (ii) 2,769,271 shares of Series D Preferred Stock beneficially owned by Fund IV (defined below), which converted into 620,551 shares of Common Stock, and (iii) 2,320,797 shares of Series D Preferred Stock beneficially owned by Fund V (defined below), which converted into 520,054 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP IV, LLC (\"GP IV\") and Cormorant Private Healthcare GP V, LLC (\"GP V\") serve as General Partner of the Master Fund, Fund IV and Fund V, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP IV  and GP V. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1179529},"source":{"system":"sec-edgar","filing":"0000929638-24-003363","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000092963824003363/form4.xml","form_type":"4"}},{"id":1396779,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":2,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":4,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2024-10-01T20:01:04.000Z","date":"2024-09-27","kind":"purchase","planned":false,"acquired":true,"shares":450000,"price":18,"value":8100000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP IV, LLC (\"GP IV\") and Cormorant Private Healthcare GP V, LLC (\"GP V\") serve as General Partner of the Master Fund, Fund IV and Fund V, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP IV  and GP V. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares of Common Stock purchased for the account of the Master Fund."}],"balance_after":1629529,"source":{"system":"sec-edgar","filing":"0000929638-24-003363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000092963824003363/form4.xml","form_type":"4"}},{"id":1396778,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25048,"kind":"organization","name":"Cormorant Private Healthcare Fund V LP","position":2,"cik":"0001969296","reported_name":"Cormorant Private Healthcare Fund V LP","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"other":true,"other_text":"Former 10% Owner"}},{"id":74741,"kind":"organization","name":"Cormorant Private Healthcare Fund IV LP","position":4,"cik":"0001871297","reported_name":"Cormorant Private Healthcare Fund IV LP","relationship":{"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2024-10-01T20:01:04.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":true,"shares":1179529,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each share of the Series D Redeemable Convertible Preferred Stock (\"Series D Preferred Stock\") automatically converted into 0.224084614 shares of Common Stock of the Issuer (\"Common Stock\") upon the closing of the Issuer's initial public offering of Common Stock.  The Series D Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (i) 173,704 shares of Series D Preferred Stock beneficially owned by the Master Fund (defined below), which converted into 38,924 shares of Common Stock, (ii) 2,769,271 shares of Series D Preferred Stock beneficially owned by Fund IV (defined below), which converted into 620,551 shares of Common Stock, and (iii) 2,320,797 shares of Series D Preferred Stock beneficially owned by Fund V (defined below), which converted into 520,054 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"), Cormorant Private Healthcare Fund IV, LP (\"Fund IV\") and Cormorant Private Healthcare Fund V, LP (\"Fund V\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\"), Cormorant Private Healthcare GP IV, LLC (\"GP IV\") and Cormorant Private Healthcare GP V, LLC (\"GP V\") serve as General Partner of the Master Fund, Fund IV and Fund V, respectively. Bihua Chen serves as manager of Cormorant, GP LLC, GP IV  and GP V. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1179529,"source":{"system":"sec-edgar","filing":"0000929638-24-003363","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000092963824003363/form4.xml","form_type":"4"}},{"id":1399919,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":25769,"price":22.228,"value":572793.332,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $22.00 to $22.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2375000,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399918,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":47564,"price":21.474,"value":1021389.336,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $21.00 to $21.99 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2349231,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399917,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":139551,"price":20.418,"value":2849352.318,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $20.00 to $20.995 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2301667,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399916,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":66088,"price":19.611,"value":1296051.768,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $19.00 to $19.998 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2162116,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399915,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":25943,"price":18.36,"value":476313.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $18.03 to $18.999 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2096028,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1399914,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-24T20:04:18.000Z","date":"2024-09-20","kind":"purchase","planned":false,"acquired":true,"shares":45085,"price":17.475,"value":787860.375,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $17.00 to $17.95 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2070085,"source":{"system":"sec-edgar","filing":"0000929638-24-003217","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824003217/form4.xml","form_type":"4"}},{"id":1480847,"issuer":{"id":6606,"kind":"organization","name":"Biomea Fusion, Inc."},"owners":[{"id":25044,"kind":"person","name":"Chen Bihua","position":1,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"director":true,"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":3,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}},{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":4,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T20:38:16.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":51025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Stock options granted to Bihua Chen, in her capacity as a director of the Issuer."}],"balance_after":51.025,"derivative":{"exercise_price":4.63,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":51025},"source":{"system":"sec-edgar","filing":"0000929638-24-002175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824002175/form4.xml","form_type":"4"}},{"id":1523098,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-08T20:23:14.000Z","date":"2024-05-06","kind":"purchase","planned":false,"acquired":true,"shares":207153,"price":12.36,"value":2560411.08,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale right of the shares purchased in a series of open market transactions on the transaction date at prices ranging from $12.08 to $12.95 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":8325000,"source":{"system":"sec-edgar","filing":"0000929638-24-001743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963824001743/form4.xml","form_type":"4"}},{"id":1523097,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-08T20:23:14.000Z","date":"2024-05-06","kind":"purchase","planned":false,"acquired":true,"shares":642847,"price":11.7,"value":7521309.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of Common Stock (the \"shares\") purchased in a series of open market transactions on the transaction date at prices ranging from $11.08 to $12.07 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":8117847,"source":{"system":"sec-edgar","filing":"0000929638-24-001743","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963824001743/form4.xml","form_type":"4"}},{"id":1537475,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-04-22T20:00:41.000Z","date":"2024-04-18","kind":"purchase","planned":false,"acquired":true,"shares":186521,"price":18.9,"value":3525246.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale right of the shares purchased in a series of open market transactions on the transaction date at prices ranging from $18.43 to $19.06 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":7475000,"source":{"system":"sec-edgar","filing":"0000929638-24-001536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963824001536/form4.xml","form_type":"4"}},{"id":1537474,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-04-22T20:00:41.000Z","date":"2024-04-18","kind":"purchase","planned":false,"acquired":true,"shares":395244,"price":17.62,"value":6964199.28,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of Common Stock (the \"shares\") purchased in a series of open market transactions on the transaction date at prices ranging from $17.36 to $18.25 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":7288479,"source":{"system":"sec-edgar","filing":"0000929638-24-001536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963824001536/form4.xml","form_type":"4"}},{"id":1549987,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":398600,"price":2.9,"value":1155940.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Represents (i) 955,689 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 1,939,584 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":2895273,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549986,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":280,"price":2.97,"value":831.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents (i) 1,086,227 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,646 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3293873,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549985,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":10,"price":2.98,"value":29.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents (i) 1,087,319 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,834 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3294153,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549984,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":10,"price":3.01,"value":30.1,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Represents (i) 1,087,322 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,841 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3294163,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549983,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":600,"price":3.03,"value":1818.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents (i) 1,087,325 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,206,848 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3294173,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549982,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.05,"value":305.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents (i) 1,087,523 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,250 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3294773,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549981,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":300,"price":3.065,"value":919.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (i) 1,087,556 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,317 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3294873,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1549980,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:37:04.000Z","date":"2024-04-01","kind":"sale","planned":false,"acquired":false,"shares":100,"price":3.07,"value":307.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (i) 1,087,655 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,518 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3295173,"source":{"system":"sec-edgar","filing":"0000929638-24-001336","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001336/form4.xml","form_type":"4"}},{"id":1572574,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-03-18T21:59:40.000Z","date":"2024-03-15","kind":"sale","planned":false,"acquired":false,"shares":400000,"price":2.141,"value":856400.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $1.90 to $2.82 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Represents (i) 1,087,688 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,585 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3295273,"source":{"system":"sec-edgar","filing":"0000929638-24-001046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001046/form4.xml","form_type":"4"}},{"id":1572573,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-03-18T21:59:40.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":11040,"price":5.968,"value":65886.72,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $5.90 to $6.18 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Represents (i) 1,487,688 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,585 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3695273,"source":{"system":"sec-edgar","filing":"0000929638-24-001046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001046/form4.xml","form_type":"4"}},{"id":1572572,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-03-18T21:59:40.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":54215,"price":5.374,"value":291351.41,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $4.90 to $5.89 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents (i) 1,498,728 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,585 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3706313,"source":{"system":"sec-edgar","filing":"0000929638-24-001046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001046/form4.xml","form_type":"4"}},{"id":1572571,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-03-18T21:59:40.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":98570,"price":4.245,"value":418429.65,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $3.90 to $4.895 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents (i) 1,552,943 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,585 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3760528,"source":{"system":"sec-edgar","filing":"0000929638-24-001046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001046/form4.xml","form_type":"4"}},{"id":1572570,"issuer":{"id":5884,"kind":"organization","name":"Immuneering Corp"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25047,"kind":"organization","name":"Cormorant Private Healthcare Fund III LP","position":4,"cik":"0001817320","reported_name":"Cormorant Private Healthcare Fund III LP","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2024-03-18T21:59:40.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":345266,"price":3.235,"value":1116935.51,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of shares of Class A Common Stock sold in a series of open market transactions on the transaction date at prices ranging from $2.90 to $3.895 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price. All of these shares were sold by the Master Fund (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\") and Cormorant Private Healthcare Fund III, LP (\"Fund III\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") and Cormorant Private Healthcare GP III, LLC (\"GP III\") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (i) 1,651,513 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,585 shares of Class A Common Stock beneficially owned by Fund III."}],"balance_after":3859098,"source":{"system":"sec-edgar","filing":"0000929638-24-001046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817320/000092963824001046/form4.xml","form_type":"4"}},{"id":1583578,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":8862,"price":45.96,"value":407297.52,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $45.88 to $46.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2025000,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583577,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":156597,"price":45.26,"value":7087580.22,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $44.84 to $45.72 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":2016138,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583576,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":61668,"price":44.62,"value":2751626.16,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $44.20 to $44.82 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1859541,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583575,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":18548,"price":43.26,"value":802386.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $43.15 to $43.82 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1797873,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583574,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":24983,"price":42.25,"value":1055531.75,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $42.24 to $42.48 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1779325,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583573,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":29342,"price":41.23,"value":1209770.66,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $40.83 to $41.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1754342,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583572,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-07","kind":"purchase","planned":false,"acquired":true,"shares":102140,"price":41.23,"value":4211232.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $40.53 to $41.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1725000,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583571,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-07","kind":"purchase","planned":false,"acquired":true,"shares":90325,"price":39.99,"value":3612096.75,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $39.55 to $40.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1622860,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583570,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-07","kind":"purchase","planned":false,"acquired":true,"shares":10736,"price":39.13,"value":420099.68,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $38.77 to $39.53 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1532535,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1583569,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-03-11T21:34:06.000Z","date":"2024-03-07","kind":"purchase","planned":false,"acquired":true,"shares":46799,"price":37.82,"value":1769938.18,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $37.53 to $38.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1521799,"source":{"system":"sec-edgar","filing":"0000929638-24-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000985/form4.xml","form_type":"4"}},{"id":1656484,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-06T21:00:46.000Z","date":"2024-02-02","kind":"purchase","planned":false,"acquired":true,"shares":750000,"price":19,"value":14250000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":1475000,"source":{"system":"sec-edgar","filing":"0000929638-24-000383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000383/form4.xml","form_type":"4"}},{"id":1666302,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":3200,"price":38.49,"value":123168.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $38.25 to $38.98 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":725000,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666301,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":43754,"price":37.49,"value":1640337.46,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $37.22 to $37.99 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":721800,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666300,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":16484,"price":36.53,"value":602160.52,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $36.15 to $37.02 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":678046,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666299,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":32295,"price":35.83,"value":1157129.85,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $35.15 to $36.11 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":661562,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666298,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":31549,"price":34.62,"value":1092226.38,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $34.17 to $35.10 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":629267,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666297,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":18055,"price":33.71,"value":608634.05,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $33.18 to $34.02 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":597718,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666296,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":3866,"price":32.47,"value":125529.02,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $32.14 to $33.01 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":579663,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666295,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":4125,"price":31.86,"value":131422.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $31.29 to $32.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":575797,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666294,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":2654,"price":31,"value":82274.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $30.99 to $31.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":571672,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666293,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":29244,"price":29.42,"value":860358.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $29.13 to $30.00 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":569018,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666292,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":31028,"price":28.82,"value":894226.96,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $28.12 to $29.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":539774,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666291,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":36747,"price":27.7,"value":1017891.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $27.13 to $28.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":508746,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666290,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":15243,"price":26.66,"value":406378.38,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $26.14 to $27.12 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":471999,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1666289,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":2,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":3,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-30T21:23:10.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":14388,"price":25.73,"value":370203.24,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $25.12 to $26.11 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the \"SEC\"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":456756,"source":{"system":"sec-edgar","filing":"0000929638-24-000304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583977/000092963824000304/form4.xml","form_type":"4"}},{"id":1680601,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-11T21:00:52.000Z","date":"2024-01-11","kind":"purchase","planned":false,"acquired":true,"shares":750000,"price":19.75,"value":14812500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":6893235,"source":{"system":"sec-edgar","filing":"0000929638-24-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963824000081/form4.xml","form_type":"4"}},{"id":1680600,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-01-11T21:00:52.000Z","date":"2024-01-09","kind":"purchase","planned":false,"acquired":true,"shares":105000,"price":21.32,"value":2238600.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of Common Stock (the \"shares\") purchased in a series of open market transactions on the transaction date at prices ranging from $20.90 to $21.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":6143235,"source":{"system":"sec-edgar","filing":"0000929638-24-000081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963824000081/form4.xml","form_type":"4"}},{"id":1713841,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-12T21:52:16.000Z","date":"2023-12-08","kind":"purchase","planned":false,"acquired":true,"shares":588235,"price":17,"value":9999995.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":6038235,"source":{"system":"sec-edgar","filing":"0000929638-23-003419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003419/form4.xml","form_type":"4"}},{"id":1719907,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":8260,"price":34.49,"value":284887.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $34.30 to $34.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5450000,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719906,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":19866,"price":33.75,"value":670477.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $33.30 to $34.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5441740,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719905,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":41824,"price":33.08,"value":1383537.92,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $32.30 to $33.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5421874,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719904,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":86713,"price":31.83,"value":2760074.79,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $31.30 to $32.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5380050,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719903,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":15582,"price":30.74,"value":478990.68,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $30.30 to $31.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5293337,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719902,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":18601,"price":29.91,"value":556355.91,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $29.30 to $30.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5277755,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719901,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":8168,"price":28.78,"value":235075.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $28.30 to $29.28 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5259154,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719900,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":27425,"price":27.87,"value":764334.75,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $27.30 to $28.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5250986,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719899,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":53109,"price":26.73,"value":1419603.57,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $26.30 to $27.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5223561,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719898,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":65086,"price":25.88,"value":1684425.68,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $25.30 to $26.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5170452,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719897,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":39899,"price":24.87,"value":992288.13,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $24.30 to $25.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5105366,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719896,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":37081,"price":24.01,"value":890314.81,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $23.30 to $24.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5065467,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}},{"id":1719895,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":25045,"kind":"organization","name":"Cormorant Asset Management, LP","position":1,"cik":"0001583977","reported_name":"Cormorant Asset Management, LP","relationship":{"ten_percent_owner":true}},{"id":25044,"kind":"person","name":"Chen Bihua","position":2,"cik":"0001599214","reported_name":"Chen Bihua","relationship":{"ten_percent_owner":true}},{"id":25046,"kind":"organization","name":"Cormorant Global Healthcare Master Fund, LP","position":3,"cik":"0001618442","reported_name":"Cormorant Global Healthcare Master Fund, LP","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-06T21:39:15.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":28090,"price":22.8,"value":640452.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $22.30 to $23.29 per share."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of the shares reported herein were purchased by the Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cormorant Asset Management, LP (\"Cormorant\") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the \"Master Fund\"). Cormorant Global Healthcare GP, LLC (\"GP LLC\") serves as General Partner of the Master Fund. Bihua Chen serves as manager of Cormorant, GP LLC. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose."}],"balance_after":5028386,"source":{"system":"sec-edgar","filing":"0000929638-23-003383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1314102/000092963823003383/form4.xml","form_type":"4"}}],"next_cursor":"2023-12-06T21:39:15.000000Z,1719895"}